News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,646 Results
Type
Article (141)
Company Profile (1)
Press Release (1504)
Section
Business (438)
Career Advice (1)
Deals (54)
Drug Development (438)
FDA (25)
Job Trends (20)
News (870)
Policy (59)
Tag
Academia (22)
Alliances (86)
ALS (2)
Alzheimer's disease (29)
Approvals (25)
Artificial intelligence (1)
Best Places to Work (11)
Biotechnology (1)
Bladder cancer (1)
Cancer (3)
Cardiovascular disease (2)
Career advice (1)
Cell therapy (2)
Clinical research (344)
Collaboration (5)
Compensation (11)
COVID-19 (8)
CRISPR (1)
C-suite (1)
Data (28)
Diagnostics (7)
Drug discovery (1)
Duchenne muscular dystrophy (1)
Earnings (168)
Events (214)
Executive appointments (2)
FDA (34)
Frontotemporal dementia (1)
Funding (8)
Gene editing (2)
Gene therapy (24)
Government (5)
Healthcare (53)
Huntington's disease (1)
Immunology and inflammation (1)
Infectious disease (8)
Intellectual property (3)
IPO (23)
Job creations (10)
Job search strategy (1)
Layoffs (4)
Legal (3)
Medical device (15)
Medtech (16)
Mergers & acquisitions (32)
Multiple sclerosis (3)
Neurodegenerative disease (13)
Neuropsychiatric disorders (1)
Neuroscience (49)
NextGen: Class of 2026 (16)
Non-profit (17)
Pain (1)
Parkinson's disease (3)
Patents (2)
Patient recruitment (6)
People (167)
Phase 1 (134)
Phase 2 (192)
Phase 3 (92)
Pipeline (19)
Policy (1)
Postmarket research (8)
Preclinical (44)
Prostate cancer (1)
Rare diseases (19)
Real estate (4)
Regulatory (61)
Research institute (10)
Rett syndrome (12)
Series A (1)
Series B (1)
Spinal muscular atrophy (1)
Startups (13)
The Weekly (1)
Date
Last 7 days (3)
Last 30 days (6)
Last 365 days (109)
2026 (9)
2025 (110)
2024 (151)
2023 (108)
2022 (140)
2021 (171)
2020 (113)
2019 (97)
2018 (57)
2017 (53)
2016 (49)
2015 (68)
2014 (64)
2013 (49)
2012 (62)
2011 (71)
2010 (66)
Location
Arizona (1)
Asia (58)
Australia (10)
California (28)
Canada (9)
China (1)
Connecticut (3)
Delaware (1)
Europe (220)
Florida (5)
Illinois (8)
Kentucky (1)
Maryland (1)
Massachusetts (37)
Minnesota (1)
New Jersey (2)
New York (41)
North Carolina (1)
Northern California (13)
Ohio (2)
Pennsylvania (1)
Rhode Island (1)
South America (1)
Southern California (7)
Texas (4)
United States (135)
Washington State (3)
1,646 Results for "neurogene".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurogene to Participate in Upcoming Investor Conferences - February 5, 2026
February 5, 2026
·
1 min read
Press Releases
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2026
February 5, 2026
·
1 min read
Press Releases
Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
1 min read
Rare diseases
FDA Signs Off on Neurogene’s ‘Best-Case Scenario’ Pivotal Study Design for Rett Syndrome
The pivotal trial for Neurogene’s Rett syndrome gene therapy makes use of baseline controls and a rigorous endpoint that could help ensure a broader label for the drug product, if approved, according to analysts.
July 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome
January 12, 2026
·
8 min read
Press Releases
Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates
November 14, 2025
·
10 min read
Press Releases
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2025
December 5, 2025
·
1 min read
Press Releases
Neurogene to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
October 9, 2025
·
1 min read
Press Releases
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 5, 2025
November 5, 2025
·
1 min read
Press Releases
Neurogene Announces First Participant Dosed in Embolden™ Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome
November 7, 2025
·
7 min read
1 of 165
Next
